Glyburide-reversible cardioprotective effects of BMS-180448: Functional and energetic considerations

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 1, 1997, Pages 28-38

  Grover, Gary J ^a   Sleph, Paul G ^a   Dzwonczyk, Steven ^a   Malone, Harold J ^a   Behling, Ronald W ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

ATP; BMS 180448; Diltiazen; Ischemia

Indexed keywords

CROMAKALIM; DILTIAZEM; GLIBENCLAMIDE; N (4 CHLOROPHENYL) N' CYANO N'' (6 CYANO 3,4 DIHYDRO 3 HYDROXY 2,2 DIMETHYL 2H 1 BENZOPYRAN 4 YL)GUANIDINE;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CONCENTRATION RESPONSE; DRUG EFFECT; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BENZOPYRANS; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; DEPRESSION, CHEMICAL; DILTIAZEM; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; GUANIDINES; HEART; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; OXYGEN CONSUMPTION; PHOSPHOCREATINE; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031012789     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199701000-00005     Document Type: Article

References (31)

1. + channels in cardiac muscle. Nature 1983;305:147-8.
2. + loss and arrhythmias in rat hearts: effect of glybenclamide, a sulfonylurea. Circ Res 1990;66:478-85.
3. + loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res 1991;69:623-37.
4. Cohen NM, Wise RM, Wechsler AS, Damiano RJ. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener: a novel form of myocardial protection. J Thorac Cardiovasc Surg 1993;106:317-28.
5. Galiñanes M, Shattock MJ, Hearse DJ. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res 1992;26:1063-8.
6. Grover GJ, Dzwonczyk S, Sleph PG. Reduction of ischemic damage in isolated rat hearts by the potassium channel opener RP 52891. Eur J Pharmacol 1990;191:11-9.
7. Atwal KS, Grover GJ, Ahmed S, et al. Cardioselective anti-ischemic ATP-sensitive potassium channel openers. J Med Chem 1993;36:3971-4.
8. Grover GJ, Sargent CA, McCullough JR, D'Alonzo AJ, Atwal KS. Cardioprotective profile of the cardiac-selective ATP-sensitive potassium channel opener BMS-180448. J Cardiovasc Pharmacol 1995;25:40-50.
9. Grover GJ, Newburger J, Sleph PG, et al. The cardioprotective effects of the potassium channel opener cromakalim: stereoselectivity and effects on myocardial adenine nucleotides. J Pharmacol Exp Ther 1991;257:156-62.
10. Yao Z, Gross GJ. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994;89:1769-75.
11. Adams H. Adenosine 5′-triphosphate determination with phosphoglycerate kinase. In: Bergmeyer HU, ed. Methods of enzymatic analysis. New York: Academic Press, 1963:539-43.
12. 31P nuclear magnetic resonance analysis of metabolite concentrations in Langendorff-perfused rabbit hearts. Biophys J 1985;48:803-13.
13. Jeffrey FM, Storey CJ, Nunnaly RL, Malloy CR. Effect of ischemia on NMR detection of phosphoryated metabolites in the intact rat heart. Biochemistry 1989;28:5323-6.
14. 31P nuclear magnetic resonance. Am J Physiol 1986;251:H171-5.
15. Dennis JE, Gay DM, Welsch RE. An adaptive nonlinear least-squares algorithm. ACM Trans Math Software 1981;7:348-68.
16. Grover GJ, Sleph PG, Dzwonczyk S. The pharmacologic profile of cromakalim in the treatment of myocardial ischemia in isolated rat hearts and anesthetized dogs. J Cardiovasc Pharmacol 1990; 16:853-64.
17. Cole WC, McPherson CD, Sontag D. ATP-regulated channels protect the myocardium against ischemia reperfusion damage. Circ Res 1991;69:571-81.
18. ATP-channel openers protect against increased cytosolic calcium during ischemia and reperfusion. J Mol Cell Cardiol 1995;27:1809-17.
19. 31P-NMR in the isolated perfused rat heart. Jpn J Pharmacol 1985;39:51-8.
20. Watts JA, Maiorano LJ, Maiorano PC. Comparison of the protective effects of verapamil, diltiazem, nifedipine, and buffer containing low calcium upon global myocardial ischemic injury. J Mol Cell Cardiol 1986;18:255-63.
21. Grover GJ, Sleph PG. Dissociation of cardiodepression from cardioprotection with calcium antagonists: diltiazem protects ischemic rat myocardium with a lower functional cost as compared with verapamil or nifedipine. J Cardiovasc Pharmacol 1989;14:331-40.
22. 31P NMR study. J Mol Cell Cardiol 1986;18:931-41.
23. Watts JA, Maiorano LJ, Maiorano PC. Protection by verapamil of globally ischemic rat hearts: energy preservation, a partial explanation. J Mol Cell Cardiol 1985;17:797-804.
24. Hearse DJ. Reperfusion of ischaemic myocardium. J Mol Cell Cardiol 1977;9:605-16.
25. Peng CF, Kane JJ, Straub KD, Murphy ML. Improvement of mitochondrial energy production in ischemic myocardium by in vivo infusion of ruthenium red. J Cardiovasc Pharmacol 1980;2: 45-54.
26. Younga P, Bowles DK, Kehrer D. Protection against hypoxic injury in isolated-perfused rat heart by ruthenium red. J Pharmacol Exp Ther 1990;253:628-35.
27. Monticello TM, Sargent C, McGill J, Barton D, Grover GJ. Protective effects of the cardio-selective ATP-sensitive potassium channel opener BMS-180448: light and electron microscopic findings. Cardiovasc Res 1996;31:93-101.
28. Grover GJ, Dzwonczyk S, Sleph PG. Ruthenium red improves postischemic contractile function in isolated rat hearts. J Cardiovasc Pharmacol 1990;16:783-9.
29. Matlib MA, Lee S-W, Depover A, Schwartz A. A specific inhibitory action of certain benzothiazepines and benzodiazepines on the sodium-calcium exchange process of heart and brain mitochondria. Eur J Pharmacol 1983;89:327-8.
30. + channels in the mitochondrial inner membrane. Nature 1991;352:244-7.
31. Grover GJ, Parham CS. Effect of intracoronary diltiazem on ST-segment elevation and myocardial blood flow during pacing-induced ischemia. J Cardiovasc Pharmacol 1987;10:548-54.